Regulatory endorsement, AI-driven omics analytics, organ-chip advances, CRO expansion, and heavy investment are propelling ...

A new study in Small presents a nanoparticle-based delivery system combining CuET and BIO for treating resistant melanoma, ...

LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today announces that preclinical data showing the wider therapeutic ...

Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

LIfT BioSciences presents latest data on its first-in-class Immunomodulatory Alpha Neutrophils at International Society for ...

A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in ...

HKUMed has achieved a significant breakthrough in developing needle-free, live-attenuated influenza vaccines with broad protection against human and ...

Lyell is advancing a pipeline of next-generation CAR T-cell product candidates. Its lead program, LYL314, is in Phase 1/2 ...

Presenting new clinical data from Phase 1/2 multi-center clinical trial of LYL314, a next-generation dual-targeting CD19/CD20 CAR T-cell product candidate for the treatment of relapsed and/or refracto ...

The purpose of this study was to compare the cytotoxicity of e-cigarette refill fluids/solvents and their corresponding aerosols using in vitro cultured cells. Methods E-cigarette refill fluids and do ...